Daniel Clark
Stock Analyst at Leerink Partners
(2.95)
# 1,619
Out of 5,090 analysts
7
Total ratings
80%
Success rate
34.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDXX IDEXX Laboratories | Maintains: Outperform | $580 → $600 | $714.10 | -15.98% | 3 | Jul 17, 2025 | |
| ZTS Zoetis | Downgrades: Market Perform | $180 → $155 | $118.65 | +30.64% | 2 | Jul 17, 2025 | |
| ELAN Elanco Animal Health | Upgrades: Outperform | $18 | $21.90 | -17.81% | 2 | Jul 17, 2025 |
IDEXX Laboratories
Jul 17, 2025
Maintains: Outperform
Price Target: $580 → $600
Current: $714.10
Upside: -15.98%
Zoetis
Jul 17, 2025
Downgrades: Market Perform
Price Target: $180 → $155
Current: $118.65
Upside: +30.64%
Elanco Animal Health
Jul 17, 2025
Upgrades: Outperform
Price Target: $18
Current: $21.90
Upside: -17.81%